{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:33Z","timestamp":1787020713471,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203727"],"award-info":[{"award-number":["82203727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273097"],"award-info":[{"award-number":["82273097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["22YF1405700"],"award-info":[{"award-number":["22YF1405700"]}]},{"name":"Natural Science Foundation of Shanghai","award":["23ZR1409700"],"award-info":[{"award-number":["23ZR1409700"]}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk00801"],"award-info":[{"award-number":["shslczdzk00801"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Necrosis plays a pivotal role in the development of cisplatin resistance in metastatic neck lymph nodes of head and neck squamous cell carcinoma (HNSCC). However, the precise mechanisms underlying this association remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We employed qPCR and DNA in situ hybridization to detect\n                      <jats:italic>Fusobacterium nucleatum<\/jats:italic>\n                      (\n                      <jats:italic>F. nucleatum<\/jats:italic>\n                      ) in postoperative tissue specimens from node-positive HNSCC patients. Transcriptomic sequencing was performed to analyze gene expression changes in adipocytes following\n                      <jats:italic>F. nucleatum<\/jats:italic>\n                      co-culture. RNA and protein expression alterations were validated via qPCR, Western blot, and ELISA. Additionally, subcutaneous xenograft tumor models were utilized for in vivo validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>F. nucleatum<\/jats:italic>\n                      was found to preferentially colonize necrotic neck lymph nodes in HNSCC and infiltrate adjacent adipocytes. In vitro,\n                      <jats:italic>F. nucleatum<\/jats:italic>\n                      induced the formation of cancer-associated adipocytes via autocrine C-C motif chemokine ligand 2 (CCL2), which stimulated lipolysis and enhanced free fatty acid release. Paracrine CCL2 further drove glutathione accumulation and cisplatin resistance in HNSCC by upregulating solute carrier family 1 member 5 (SLC1A5) and solute carrier family 7 member 11 (SLC7A11). Notably, C-C chemokine receptor type 2 (CCR2) antagonist, RS504393, effectively reversed these\n                      <jats:italic>F. nucleatum<\/jats:italic>\n                      -mediated pro-tumor effects. In vivo studies further confirmed the role of\n                      <jats:italic>F. nucleatum<\/jats:italic>\n                      -reprogrammed adipocytes and the therapeutic potential of RS504393.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study is the first to elucidate the crucial involvement of\n                      <jats:italic>F. nucleatum<\/jats:italic>\n                      in shaping cancer-associated adipocytes within the HNSCC microenvironment.\n                      <jats:italic>F. nucleatum<\/jats:italic>\n                      -reprogrammed adipocytes enhance cisplatin resistance via the CCL2-CCR2 axis, offering new therapeutic avenues to overcome chemotherapy resistance in necrotic neck lymph nodes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Fusobacterium nucleatum<\/jats:italic>\n                      (\n                      <jats:italic>F. nucleatum<\/jats:italic>\n                      ) drives the transformation of adipocytes into a cancer-associated phenotype via autocrine CCL2 signaling. This process increases free fatty acid release to fuel tumor progression by enhancing lipolysis through the activation of CREB\/HSL phosphorylation. Additionally, paracrine CCL2 from\n                      <jats:italic>F.\u00a0nucleatum<\/jats:italic>\n                      -reprogrammed adipocytes upregulates SLC1A5 and SLC7A11 in head and neck squamous cell carcinoma (HNSCC), leading to glutathione (GSH) accumulation and cisplatin resistance. Pharmacological inhibition of CCR2 with RS504393 attenuates both cancer-associated adipocyte formation and cisplatin resistance, highlighting the therapeutic potential of targeting the CCL2-CCR2 axis in HNSCC.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-025-02550-z","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T23:42:47Z","timestamp":1763941367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fusobacterium nucleatum-reprogrammed adipocytes promote tumor cisplatin resistance through the CCL2-CCR2 axis in the necrotic metastatic neck nodes of head and neck carcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Feiran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ching","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yao","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"8","key":"2550_CR1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3109\/00016489.2014.894252","volume":"134","author":"N HANAI","year":"2014","unstructured":"Hanai N, Ozawa T, Hirakawa H, et al. The nodal response to chemoselection predicts the risk of recurrence following definitive chemoradiotherapy for pharyngeal cancer [J]. Acta Otolaryngol. 2014;134(8):865\u201371.","journal-title":"Acta Otolaryngol"},{"issue":"8","key":"2550_CR2","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1288\/00005537-199208000-00015","volume":"102","author":"SG WOLF G T, FISHER","year":"1992","unstructured":"Wolf G T, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation [J]. Laryngoscope. 1992;102(8):934\u20139.","journal-title":"Laryngoscope"},{"issue":"8","key":"2550_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hed.20580","volume":"29","author":"SL LIAUW","year":"2007","unstructured":"Liauw SL, Amdur RJ, Morris CG, et al. Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck [J]. Head Neck. 2007;29(8):715\u20139.","journal-title":"Head Neck"},{"key":"2550_CR4","doi-asserted-by":"crossref","unstructured":"Li F, Hsueh C, Huang H, et al. A nomogram to predict nodal response after induction chemotherapy for hypopharyngeal carcinoma [J]. Laryngoscope. 2022; 133(4):849\u201355","DOI":"10.1002\/lary.30241"},{"key":"2550_CR5","doi-asserted-by":"publisher","first-page":"14706","DOI":"10.1038\/ncomms14706","volume":"8","author":"HUANG C K","year":"2017","unstructured":"Huang CK, Chang PH, Kuo WH, et al. Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via \u03b2-hydroxybutyrate [J]. Nat Commun. 2017;8:14706.","journal-title":"Nat Commun"},{"issue":"8","key":"2550_CR6","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1111\/cas.14527","volume":"111","author":"M TAKEHARA","year":"2020","unstructured":"Takehara M, Sato Y, Kimura T, et al. Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression [J]. Cancer Sci. 2020;111(8):2883\u201394.","journal-title":"Cancer Sci"},{"issue":"8","key":"2550_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.bbalip.2019.04.006","volume":"1864","author":"W HU","year":"2019","unstructured":"Hu W, Ru Z, Zhou Y, et al. Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway [J]. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(8):1091\u2013102.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"11","key":"2550_CR8","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"NIEMAN K M","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth [J]. Nat Med. 2011;17(11):1498\u2013503.","journal-title":"Nat Med"},{"issue":"1","key":"2550_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12964-018-0309-z","volume":"16","author":"SJ HE J Y, WEI X H, LI","year":"2018","unstructured":"He JY, Wei XH, Li SJ, et al. Adipocyte-derived IL-6 and leptin promote breast cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression [J]. Cell Commun Signal. 2018;16(1):100.","journal-title":"Cell Commun Signal"},{"key":"2550_CR10","doi-asserted-by":"crossref","unstructured":"Zhang Q, Deng T, Zhang H et al. Adipocyte-Derived Exosomal MTTP suppresses ferroptosis and promotes chemoresistance in colorectal cancer [J]. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2022;9(28):e2203357.","DOI":"10.1002\/advs.202203357"},{"issue":"6","key":"2550_CR11","doi-asserted-by":"publisher","first-page":"e32118","DOI":"10.1371\/journal.pone.0032118","volume":"7","author":"K LI","year":"2012","unstructured":"Li K, Bihan M, Yooseph S, et al. Analyses of the microbial diversity across the human Microbiome [J]. PLoS ONE. 2012;7(6):e32118.","journal-title":"PLoS ONE"},{"issue":"6","key":"2550_CR12","doi-asserted-by":"publisher","first-page":"e66476","DOI":"10.1371\/journal.pone.0066476","volume":"8","author":"HL GONG","year":"2013","unstructured":"Gong HL, Shi Y, Zhou L, et al. The composition of Microbiome in larynx and the throat biodiversity between laryngeal squamous cell carcinoma patients and control population [J]. PLoS ONE. 2013;8(6):e66476.","journal-title":"PLoS ONE"},{"issue":"23","key":"2550_CR13","doi-asserted-by":"publisher","first-page":"7356","DOI":"10.1128\/AEM.02329-14","volume":"80","author":"H GONG","year":"2014","unstructured":"Gong H, Shi Y, Zhou X, et al. Microbiota in the throat and risk factors for laryngeal carcinoma [J]. Appl Environ Microbiol. 2014;80(23):7356\u201363.","journal-title":"Appl Environ Microbiol"},{"key":"2550_CR14","doi-asserted-by":"crossref","unstructured":"Hsueh CY, Gong H, Cong N, et al. Throat microbial community structure and functional changes in postsurgery laryngeal carcinoma patients [J]. Appl Environ Microbiol. 2020;86(24):e01849\u201320.","DOI":"10.1128\/AEM.01849-20"},{"issue":"1","key":"2550_CR15","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1038\/s41598-017-05576-7","volume":"7","author":"H GONG","year":"2017","unstructured":"Gong H, Shi Y, XiaO X, et al. Alterations of microbiota structure in the larynx relevant to laryngeal carcinoma [J]. Sci Rep. 2017;7(1):5507.","journal-title":"Sci Rep"},{"issue":"2","key":"2550_CR16","doi-asserted-by":"publisher","first-page":"103829","DOI":"10.1016\/j.isci.2022.103829","volume":"25","author":"Y HSUEH C","year":"2022","unstructured":"Hsueh C Y, Huang Q, Gong H, et al. A positive feed-forward loop between Fusobacterium nucleatum and ethanol metabolism reprogramming drives laryngeal cancer progression and metastasis [J]. iScience. 2022;25(2):103829.","journal-title":"iScience"},{"issue":"17","key":"2550_CR17","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1002\/cncr.34338","volume":"128","author":"CY Hsueh","year":"2022","unstructured":"Hsueh CY, Lau HC, Huang Q, et al. Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck [J]. Cancer. 2022;128(17):3170\u201384.","journal-title":"Cancer"},{"key":"2550_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2407-9-85","volume":"9","author":"HR Park","year":"2009","unstructured":"Park HR, Ju EJ, Jo SK, et al. Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice [J]. BMC Cancer. 2009;9:85.","journal-title":"BMC Cancer"},{"issue":"1","key":"2550_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13046-024-03002-1","volume":"43","author":"F Yang","year":"2024","unstructured":"Yang F, Yuan C, Chen F, et al. Combined IL6 and CCR2 Blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer [J]. J Exp Clin Cancer Res. 2024;43(1):76.","journal-title":"J Exp Clin Cancer Res"},{"key":"2550_CR20","doi-asserted-by":"crossref","unstructured":"Yu J, Chen Y, Fu X, et al. Invasive Fusobacterium nucleatum May play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway [J]. Int J Cancer. 2016;139(6):1318\u201326.","DOI":"10.1002\/ijc.30168"},{"key":"2550_CR21","doi-asserted-by":"crossref","unstructured":"Furukawa N, Ongusaha P, Jahng WJ, et al. Role of Rho-kinase in regulation of insulin action and glucose homeostasis [J]. Cell Metab. 2005;2(2):119\u201329.","DOI":"10.1016\/j.cmet.2005.06.011"},{"key":"2550_CR22","doi-asserted-by":"crossref","unstructured":"Fontana F, Anselmi M. Carollo E, Adipocyte-Derived extracellular vesicles promote prostate cancer cell aggressiveness by enabling multiple phenotypic and metabolic changes [J]. Cells. 2022;11(15):2388.","DOI":"10.3390\/cells11152388"},{"key":"2550_CR23","doi-asserted-by":"crossref","unstructured":"Maguire OA, Ackerman SE, Szwed SK, et al. Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer [J]. Cell Metab. 2021;33(3):499\u2013e5126.","DOI":"10.1016\/j.cmet.2021.01.018"},{"key":"2550_CR24","doi-asserted-by":"crossref","unstructured":"Newman NK, Zhang Y, Padiadpu J, et al. Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome [J]. Microbiome. 2023;11(1):208.","DOI":"10.1186\/s40168-023-01637-4"},{"key":"2550_CR25","doi-asserted-by":"crossref","unstructured":"Cani PD, Van Hul M. Gut microbiota in overweight and obesity: crosstalk with adipose tissue [J]. Nat Rev Gastroenterol Hepatol. 2024;21(3):164\u201383.","DOI":"10.1038\/s41575-023-00867-z"},{"issue":"Suppl 4","key":"2550_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1469-0691.2012.03866.x","volume":"18","author":"PD Cani","year":"2012","unstructured":"Cani PD. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue [J]. Clin Microbiol Infect. 2012;18(Suppl 4):50\u20133.","journal-title":"Clin Microbiol Infect"},{"key":"2550_CR27","doi-asserted-by":"crossref","unstructured":"Yamaguchi M, Nishimura F, Naruishi H, et al. Thiazolidinedione (pioglitazone) blocks P. gingivalis- and F. nucleatum, but not E. coli, lipopolysaccharide (LPS)-induced interleukin-6 (IL-6) production in adipocytes [J]. J Dent Res. 2005;84(3):240\u20134.","DOI":"10.1177\/154405910508400306"},{"key":"2550_CR28","doi-asserted-by":"crossref","unstructured":"Liu SC, Tsang NM Leepj, et al. Epstein-Barr virus induces adipocyte dedifferentiation to modulate the tumor microenvironment [J]. Cancer Res. 2021;81(12):3283\u201394.","DOI":"10.1158\/0008-5472.CAN-20-3121"},{"key":"2550_CR29","doi-asserted-by":"crossref","unstructured":"Planellas P, Cornejo L, Farr\u00e9s R et al. Prognostic significance of the microbiome-adipose tissue axis in rectal cancer: protocol of a prospective observational study [J]. BJS Open. 2022;6(2):zrac009.","DOI":"10.1093\/bjsopen\/zrac009"},{"issue":"4","key":"2550_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/(SICI)1097-0347(199707)19:4<266::AID-HED4>3.0.CO;2-Z","volume":"19","author":"DT Chua","year":"1997","unstructured":"Chua DT, Sham JS, Kwong DL, et al. Evaluation of cervical nodal necrosis in nasopharyngeal carcinoma by computed tomography: incidence and prognostic significance [J]. Head Neck. 1997;19(4):266\u201375.","journal-title":"Head Neck"},{"key":"2550_CR31","doi-asserted-by":"crossref","unstructured":"Liang SB, Chen LS, Yang XL, et al. Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma [J]. Radiother Oncol. 2021;155:219\u201325.","DOI":"10.1016\/j.radonc.2020.11.011"},{"key":"2550_CR32","doi-asserted-by":"crossref","unstructured":"Fu JY, Yue XH, Dong M J, et al. Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer [J]. Cancer Med. 2023;12(3):2417\u201326.","DOI":"10.1002\/cam4.5075"},{"issue":"3","key":"2550_CR33","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s00330-022-09201-8","volume":"33","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Liang Z, Chen K, et al. A dynamic nomogram combining tumor stage and magnetic resonance imaging features to predict the response to induction chemotherapy in locally advanced nasopharyngeal carcinoma [J]. Eur Radiol. 2023;33(3):2171\u201384.","journal-title":"Eur Radiol"},{"key":"2550_CR34","doi-asserted-by":"crossref","unstructured":"Zapletal E, Vasiljevic T, Busson P et al. Dialog beyond the grave: necrosis in the tumor microenvironment and its contribution to tumor growth [J]. Int J Mol Sci. 2023;24(6):5278.","DOI":"10.3390\/ijms24065278"},{"key":"2550_CR35","doi-asserted-by":"crossref","unstructured":"Karsch-Bluman A, Feiglin A, Arbib E, et al. Tissue necrosis and its role in cancer progression [J]. Oncogene. 2019;38(11):1920\u201335.","DOI":"10.1038\/s41388-018-0555-y"},{"key":"2550_CR36","doi-asserted-by":"crossref","unstructured":"Rajasekaran K, Carey RM, Lin X, et al. The Microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis [J]. Oral Oncol. 2021;117:105305.","DOI":"10.1016\/j.oraloncology.2021.105305"},{"key":"2550_CR37","doi-asserted-by":"crossref","unstructured":"Fu A, Yao B, Dong T, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer [J]. Cell. 2022;185(8):1356\u2013e7226.","DOI":"10.1016\/j.cell.2022.02.027"},{"key":"2550_CR38","doi-asserted-by":"crossref","unstructured":"Iwamoto H, Izumi K, Nakagawa R et al. Serum CCL2 is a prognostic biomarker for Non-Metastatic Castration-Sensitive prostate cancer [J]. Biomedicines. 2022;10(10):2369.","DOI":"10.3390\/biomedicines10102369"},{"key":"2550_CR39","doi-asserted-by":"crossref","unstructured":"Dong Y, Zhang S, ZHAO S, et al. CCL2 promotes lymphatic metastasis via activating RhoA and Rac1 pathway and predict prognosis to some extent in tongue cancer [J]. Cancer Biol Ther. 2023;24(1):2205342.","DOI":"10.1080\/15384047.2023.2205342"},{"key":"2550_CR40","doi-asserted-by":"crossref","unstructured":"Qian Y, DING P, Xu J, et al. CCL2 activates AKT signaling to promote Glycolysis and chemoresistance in glioma cells [J]. Cell Biol Int. 2022;46(5):819\u201328.","DOI":"10.1002\/cbin.11778"},{"key":"2550_CR41","doi-asserted-by":"crossref","unstructured":"Sun W, Wang X, Wang D et al. CD40\u00d7HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer [J]. J Immunother Cancer. 2022;10(7):e005063.","DOI":"10.1136\/jitc-2022-005063"},{"issue":"1","key":"2550_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-020-01165-x","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang H, Zhang Q, Xu M, et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis [J]. Mol Cancer. 2020;19(1):41.","journal-title":"Mol Cancer"},{"key":"2550_CR43","doi-asserted-by":"crossref","unstructured":"Nywening TM, Wang-Gillam A, Sanford D E, et al. Targeting tumour-associated macrophages with CCR2 Inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial [J]. Lancet Oncol. 2016;17(5):651\u201362.","DOI":"10.1016\/S1470-2045(16)00078-4"},{"key":"2550_CR44","doi-asserted-by":"crossref","unstructured":"Pervushin NV, Yapryntseva MA, Panteleev MA, et al. Cisplatin resistance and metabolism: simplification of complexity [J]. Cancers (Basel). 2024;16(17):3082.","DOI":"10.3390\/cancers16173082"},{"key":"2550_CR45","doi-asserted-by":"crossref","unstructured":"Guo J, Satoh K, Tabata S, et al. Reprogramming of glutamine metabolism via glutamine synthetase Silencing induces cisplatin resistance in A2780 ovarian cancer cells [J]. BMC Cancer. 2021;21(1):174.","DOI":"10.1186\/s12885-021-07879-5"},{"key":"2550_CR46","doi-asserted-by":"crossref","unstructured":"Liu WJ, Pan PY, Sun Y, et al. Deferoxamine counteracts cisplatin resistance in A549 lung adenocarcinoma cells by increasing vulnerability to glutamine Deprivation-Induced cell death [J]. Front Oncol. 2021;11:794735.","DOI":"10.3389\/fonc.2021.794735"},{"key":"2550_CR47","doi-asserted-by":"crossref","unstructured":"Shen X, Wang G, He H, et al. SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer [J]. Breast Cancer (Tokyo Japan). 2024;31(1):96\u2013104.","DOI":"10.1007\/s12282-023-01516-8"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02550-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02550-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02550-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:58:19Z","timestamp":1767049099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02550-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2550"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02550-z","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"546"}}